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animals, and plants, but estrogens in contra-
ceptives and hormone replacement therapy,
those given to agricultural animals, and
industrial chemicals that mimic estro-
gen add to the enormous volume of
biologically active compounds in the
environment. These compounds are
among the PPCP (pharmaceutical and
personal care product) category of contaminants that,
when excreted, make their way into surface and ground-
water, wastewater treatment plants, and, eventually,
back into drinking water supplies. Now scientists are
looking to catalysts called Fe-TAML® (iron plus tetra-
amido macrocyclic ligand) activators as a promising way
to remove these contaminants from wastewater.
The Estrogen Question
Estrogens are among the most potent chemicals in
nature; although environmental concentrations of these
compounds are typically low, the low dose response of
animals to estrogens makes their introduction into the
environment a concern. The most potent naturally occur-
ring female hormone is 17β-estradiol; the synthetic ver-
sion, 17β-ethinylestradiol, is used in birth control pills.
According to a paper published in the 1 July 2004 issue
of Environmental Science & Technology, cows and swine
in the United States excrete a daily mix of 10–30 kg of
17β-estradiol and 20–80 kg of estrone, a major metabo-
lite of estrogen—likely over an order of magnitude high-
er than what the human population puts out.
Disruptions in estrogens’ balance have been linked to
a variety of cancers, malformation of reproductive organs,
sperm abnormalities, and other consequences in animals.
As summarized in a paper in the April 2006 EHP Ecology
Special Issue by Melanie Gross-Sorokin and others, many
studies have reported reproductive abnormalities in fish
living in waters downstream of estrogen-containing
wastewater discharges in the United States and Europe. 
But although there is little disagreement among
researchers that estrogenic compounds in the environ-
ment can have negative effects in animals, especially on
pre- and postnatal developmental processes, there is far
less agreement on the type and magnitude of effects in
both humans and other organisms from chronic low-level
exposures to reproductive hormones and hormone-
mimicking chemicals. The type and magnitude of effects
from combinations of such compounds also have not yet
been clearly elucidated. Thomas White, a technical con-
sultant for the Pharmaceutical Research and Manu-
facturers of America, says, “Based on preliminary human
health assessments for about twenty-six pharmaceutical
compounds, we believe there is no appreciable risk to
human health from pharmaceuticals in the environment.
More research is necessary in order to make this same
assessment for potential ecological impacts.” 
To measure the magnitude of PPCPs and other
emerging contaminants in national waters, the USGS
analyzed 139 streams around the United States in 1999
and 2000 for 95 organic wastewater contaminants. Of
13 compounds that affect reproduction, including estro-
genic and androgenic compounds, 1 or more were found
at 37% of the sites. 17β-ethinylestradiol was found in
5.7% of samples, 17β-estradiol in 10%. The median
detectable concentration of 17β-ethinylestradiol was
0.094 µg/L, of 17β-estradiol, 0.009 µg/L. The sites
included mostly areas with probable contamination from
human, industrial, and agricultural wastewater, so these
findings should not be considered representative of all
streams in the United States, according to the report,
which appeared in the 15 March 2002 issue of
Environmental Science & Technology.
The report observes that even though nonprescrip-
tion drugs were found in much greater concentrations,
“measured concentrations of reproductive hormones may
have greater implications for health of aquatic organisms”
because these compounds can have deleterious effects at
exposures in the range of 0.001 µg/L. The USGS find-
ings suggested that some environmental exposures are
above levels where effects have been observed in fish. The
USGS report also states that the presence of organic
wastewater contaminants at the national scale observed in
the study implies that current wastewater treatment and
natural biodegradation are inadequate to completely
remove them from water.
Thus, an effective method of removing estrogens,
their metabolites, and chemical mimics may become
more important as the science evolves, and wastewater
treatment plants and drinking water systems may eventu-
ally be required to treat source waters for estrogens. The
EPA announced in August 2005 that some PPCPs may
be added to its next contaminant candidate list, a means
of prioritizing research goals with the possibility of even-
tual regulation. The next list is expected in 2008. 
The Fe-TAML Approach
Fe-TAMLs were first developed by a research team led
by Terrence Collins at Carnegie Mellon University’s
Institute for Green Oxidation Chemistry. The elegant
Fe-TAML molecule features an iron atom in its center,
surrounded by four nitrogen atoms, which in turn are
corralled by a ring of carbon atoms. Water molecules
can loosely attach to the vertical pole of the iron atom as
ligands. If hydrogen peroxide is present, it can displace a
water ligand and create a catalyst that triggers oxidation
reactions with other compounds in the solution. 
In studies presented on 29 June 2006 at the Green
Chemistry and Engineering Conference in Washington,
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cDC, Nancy Shappell, a research physiologist
with the USDA Agricultural Research
Service in Fargo, North Dakota, demon-
strated that these catalysts can work with
hydrogen peroxide to rapidly break down
17β-estradiol and 17β-ethinylestradiol.
Depending on temperature and other condi-
tions, 17β-estradiol has a natural half-life of
about a week, whereas 17β-ethinylestradiol
takes about twice that time. In Shappell’s
laboratory experiments, developed in collab-
oration with the Institute for Green
Oxidation Chemistry, the Fe-TAML
process neutralized trace quantities of both
estrogens in a mere five minutes. In work
first reported in the January–February 2006
issue of the Journal of Environmental
Quality, Shappell has also begun quantifying
the background levels of estrogenic activity
of surface waters in order to put the anthro-
pogenic contributions in context. 
The orange Fe-TAML catalyst is first
dissolved in water and then added to the
solution containing the target chemical. It
works at room temperature and up to at
least 90°C, according to team member
Colin Horwitz, a Carnegie Mellon research
professor. The group has found that Fe-
TAMLs together with hydrogen peroxide
can rapidly degrade not only estrogenic
compounds, but also bacterial spores similar
to those of anthrax, sulfur compounds in
motor fuels, dyes in textile mill wastewater,
and organic colorants discharged from pulp
and paper mills. Fe-TAML catalyst processes
also degrade organophosphorus pesticides as
well as their toxic degradation intermediates,
some of which have been implicated as
endocrine disruptors, says Horwitz. How-
ever, at the current stage of development,
Fe-TAML activators work poorly with poly-
chlorinated biphenyls. 
Shappell cautions that although the
Fe-TAML catalyst process “is very effective
at destroying synthetic estradiol and also
several other estrogens, whether it’s going
to be effective in an organic matrix such as
wastewater is another issue that we haven’t
evaluated yet.” Currently the Fe-TAML
technology is somewhere between the
proof-of-principle stage of investigation
and the small-scale pilot plant stage of
development, according to Horwitz. 
He expects the base catalyst to be avail-
able in “small ton quantities” within about
two years, adding that the technology may
initially be a niche technology before it
becomes applicable in large wastewater facil-
ities. However, the catalyst appears to be
very efficient. In the pulp and paper applica-
tion—the only one thus far to use actual
wastewater instead of an isolated target
chemical in the laboratory—2 metric tons of
the catalyst could treat a year’s worth of
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Now you see it, now you don’t. (top) Textile dye has been added to two of three vials of
water. (middle) Colin Horwitz adds the Fe-TAML activator and hydrogen peroxide to the third vial,
which contains dye. (bottom) The catalyst removes the dye, leaving the liquid clear.pulp from a mill producing 300 metric tons
per day, says Horwitz.
A Pipe Dream?
People on the front lines of water treat-
ment tend to be skeptical of contaminant
cleanup claims that sound too good to
be true, although among the treatment
community there is great interest in the
Fe-TAML technology. Portland, Oregon’s
municipal water treatment department
participated in the USGS survey, and
Chuck Lytle, manager of Portland’s Water
Pollution Control Laboratory, calls emerg-
ing contaminants including hormones an
“extremely new and hot topic.” But the
city is not yet gearing up to treat for
PPCPs. “We are not proactive,” Lytle
observes, because waterworks companies
and city bureaus generally wait for the EPA
and state environmental quality depart-
ments to lay down the fiats regarding
removal of additional contaminants. 
The Carnegie Mellon team aims to cre-
ate thoroughly green chemistry—that is,
chemicals and processes that don’t create
more problems than they solve. Theo
Colborn, president of the Colorado-based
Endocrine Disruption Exchange, says, “I
think it’s exciting what they’re trying to do”
but asks, “do they really know what they’re
breaking [compounds] into?” In some cases
bacteria will reconstruct the metabolites
back into the original compound. Similarly,
Christian Daughton, chief of the Envi-
ronmental Chemistry Branch at the EPA
National Exposure Research Laboratory,
says there are “other solutes that are also
present at the same time, most of which
may not even be characterized and which
will also engage in oxidative reactions” in
the presence of the catalyst. 
However, according to Horwitz, tests
have shown that the catalyst itself is non-
toxic to aquatic biota, and the degradation
by-products are also benign. In the 12 April
2002 issue of Science and the January 2006
issue of the Journal of the American
Chemical Society, the Carnegie Mellon
team published the breakdown profile for
pollutants such as pentachlorophenol,
2,4,6-trichlorophenol, and fenitrothion,
where Fe-TAML processes appeared to pro-
vide an effective, nontoxic approach.
Horwitz agrees that concerns about cre-
ating unintended products are valid, espe-
cially since “all waste streams are different,
and they can change over a very short
time.” Carnegie Mellon has conducted col-
laborative studies with New Zealand
researchers L. James Wright, a professor at
the University of Auckland, and Trevor
Stuthridge at biomedical research institute
Scion Research with the Fe-TAML/H2O2
system. “We have now done toxicity testing
after treatment of some pesticides, chlori-
nated phenols, bisphenol A, some organic
dyes, and some pharmaceuticals, and in all
cases we find that the toxicity of the treated
sample is lower than the untreated sam-
ples,” Horwitz says. “In some cases, it
appears as though toxicity after treatment is
essentially zero.”
Many wastewater treatment plants rely
on biological degradation of contaminants
by bacteria, but this is often not effective
for all contaminants. Membrane filtration,
including reverse osmosis, is a proven way
to remove the majority of chemicals, but
it is energy-intensive and expensive, says
Jean Debroux, a scientist/engineer with
the San Francisco–based engineering and
environmental sciences consulting firm
Kennedy/Jenks. In addition, Debroux
says, “For every two gallons of water you
treat with reverse osmosis membranes,
you end up with approximately one gallon
of [treated] water and one gallon of the
rejects, which concentrates everything in
that water. So now you have to do some-
thing with that.” Thus, if the speed of
estrogen degradation by the Fe-TAML
catalyst holds up in large-scale applica-
tions without generating further toxic
compounds, it would be a major boon to
wastewater treatment. 
In terms of potential effects, Shappell
feels the next step should be to characterize
the fate of estrone, which she says is present
in wastewater in “much higher concentra-
tions” than 17β-estradiol. The Fe-TAML
catalyst degraded estrone about as efficient-
ly as the estradiol in Shappell’s test of the
catalyst. Estrone’s potency ranges from
one-tenth to one-hundredth that of 17β-
estradiol, depending on species and assay.
“While estradiol has been the focus of envi-
ronmental measurements,” Shappell says,
“typically the waste has very little once it
has sat around any length of time, and in
fact estrone is the primary player. I think
someone needs to do generational studies
on fish to determine concentration of
estrone that results in sterile males.” 
The Fe-TAML catalyst seems to offer
almost magical solutions to a variety of
wastewater problems, but much refinement
of the process remains to be done, and not
all stakeholders are yet convinced such treat-
ment is necessary, especially with respect to
PPCPs. But in a world where the environ-
mental news is all too often disheartening,
Fe-TAMLs offer a glow of hope that the
massive power of chemistry can mitigate
some of the problems of modern life.
Valerie J. Brown
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